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Wound Healing in Membrane-Type-1 Matrix
Metalloproteinase-Deﬁcient Mice1
To the Editor:
Matrix metalloproteinases (MMP) are a family of at least 24
Zn2þ -dependent endopeptidases comprising secreted
MMP and membrane-type MMP (MT-MMP). These en-
zymes have been implicated in wound repair by their ability
to remodel extracellular matrix (ECM) components. Indis-
criminate pharmacologic inhibition of MMP also blocks
epithelial resurfacing emphasizing the physiological role of
one or more MMP in wound healing (Lund et al, 1999; A˚gren
et al, 2001; Mirastschijski et al, 2002). Membrane-type-1
MMP (MT1-MMP) is an interesting candidate, due to its
unique anchorage to the cell membrane, which facilitates
localized pericellular proteolysis by the extracellular cata-
lytic domain during keratinocyte movement (Seiki, 2002). In
addition, MT1-MMP processes several cell surface-associ-
ated molecules and can regulate integrin cross-talk (Baciu
et al, 2003).
The precise role of MT1-MMP in epithelial regeneration is
unclear. Although MT1-MMP is expressed by normal human
(Nagavarapu et al, 2002) and murine (Netzel-Arnett et al,
2002) epidermal keratinocytes, in situ hybridization studies
failed to detect MT1-MMP gene expression in epithelium of
human (Mirastschijski et al, 2002) or murine wounds (Mad-
lener et al, 1998).
We have compared wound healing in vivo and epider-
malization specifically ex vivo in neonatal MT1-MMP-defi-
cient (MT1-MMP/) mice with their normal littermates.
Generation of MT1-MMP mutant C57BL/6 mice are
described elsewhere (Zhou et al, 2000). Following mating
of heterozygotes, MT1-MMP-deficient (MT1-MMP/), he-
terozygote (MT1-MMPþ /), and wild-type (MT1-MMPþ /þ )
offspring were obtained in Mendelian ratio. The genotype of
all animals used was verified with Southern analysis. The
phenotype of heterozygous and wild-type mice is indistin-
guishable whereas the homozygous mutated genotype ex-
hibits several developmental defects. Two to three litters,
each comprising four to six pups, were kept per cage and
breast fed. Lactating mice were given pellets and tap water
ad libitum, and kept at 201C and 50% relative humidity
in sterile animal facilities. The local ethics committees of
the Karolinska Institute (N 218-02) and Lund University (LU
508-99) approved the studies.
One full-thickness skin wound was made on the back by a
sterile 4-mm punch biopsy in anaesthetized 3-d-old animals.
Total content of hydroxyproline of excised skin biopsies did
not differ significantly between normal (10.4  0.8 mg, n¼11)
and MT1-MMP/ (10.9  0.6 mg, n¼ 8) mice. This is in
contrast to the observed skin fibrosis in MT1-MMP null mice
indicative of excessive collagen accumulation (Holmbeck
et al, 1999). The wounds were left uncovered for 7 d.
We first confirmed that wound healing in general was
dependent on MMP in our neonatal mouse wound model by
using the broad-spectrum MMP inhibitor GM 6001 that re-
sulted in marked delayed wound closure (Fig 1A). In con-
trast, wound closure was unaltered in MT1-MMP/ mice
over 7 d (Fig 1B). The density of inflammatory cells or blood
vessels in granulation tissue did not differ significantly be-
tween MT1-MMP/ mice and their littermates over the 7-d
period as evaluated semiquantitatively by light microscopy.
Gelatin zymography showed increased levels of latent
MMP-9 and MMP-2 post-wounding. MMP-9 was less
abundant in MT1-MMP/ relative to littermate wounds.
The identity of mouse MMP-9 and MMP-2 was indicated by
their positions corresponding to human MMP-9 and MMP-
2. Although MT1-MMP is an important activator of MMP-2,
the activation of pro-MMP-2 in MT1-MMP/ non-wounded
skin or wounds was only slightly reduced (Fig 1C). Addition
of dithiothreitol to tissue extracts during electrophoresis
abolished the MMP-2 lysis bands, indicating that other
MMP at the positions of the MMP-2 forms were not de-
tected in our zymographic assay. Another support for the
identity of MMP-2 was that 4-aminophenylmercuric acetate
treatment of tissue extracts resulted in a shift to lower-
molecular-mass MMP-2 forms and accumulation of active
MMP-2 (Fig 1D). The minor effect of MT1-MMP deficiency
on pro-MMP-2 activation could be explained by the ability
of the other five MT-MMP, including the glycosyl-phospha-
tidyl inositol-anchored MT-MMP, to activate latent MMP-2.
Taken together, overlapping functions of the MT-MMP and
other members of the MMP family may compensate for the
absence of functional MT1-MMP in vivo and supports the
concept of redundant activity among the MMP. In accord-
ance with our results, other MMP knockout mouse strains
display no or only minimal skin wound healing defects
(Parks, 1999).
The fragility of the MT1-MMP/ mice (Zhou et al, 2000)
limited the open wound area accessible for epithelialization
to about 5 mm2 due to substantial wound contraction. To
study centrifugal epidermalization over a larger surface ar-
ea, fresh 2-mm skin explants from 3-d-old normal and MT1-
MMP/ mice were cultured ex vivo on an acellular human
deepidermized dermal (DED) substrate. Laminin-1 immuno-
1Presented, in part, at the Joint meeting of the European Tissue
Repair Society and Wound Healing Society, Baltimore, May 2002
and awarded First Prize in the Young Investigators session.
Abbreviations: DED, deepidermized dermis; ECM, extracellular
matrix; MMP, matrix metalloproteinase; MT1-MMP, membrane-
type-1 matrix metalloproteinase
Copyright r 2004 by The Society for Investigative Dermatology, Inc.
600
staining showed an intact basement membrane on the api-
cal side of the DED substrate (Fig 2A) onto which the mouse
skin explants were secured by fibrin and grown at the air–
liquid interface for up to 9 d (Fig 2B, C). Negligible kera-
tinocyte outgrowth was observed after ablation of 100 mm of
the apical surface of DED in a cryomicrotome. The rate of
epithelial outgrowth was assessed by exposing explants to
2.4 mM fluorescein diacetate with subsequent quantification
of the fluorescent epithelium from digitized images (Lu and
Rollman, 2004). After an initial phase of comparable out-
growth rates, epithelialization was retarded in the MT1-
MMP/ group when epithelial outgrowth reached 6–7 mm2
(Fig 2D–F). In a separate but otherwise identical series, us-
ing skin explants from several different litters of mutant
(n¼30) and normal mice (n¼ 46), impaired epithelial out-
growth (po0.01) from MT1-MMP/ skin explants was re-
confirmed as outgrowth areas approached 6–7 mm2. Thus,
the in vivo and ex vivo results may not be contradictory.
Overall regeneration of neoepithelium is the net result of
keratinocyte migration, proliferation, and apoptosis. We
could not detect a significant involvement of MT1-MMP in
cell proliferation (Fig 2G–I); however, the reduced formation
of epithelium was linked to an increased proportion of apo-
ptotic MT1-MMP/ keratinocytes (24.8%  3.2%) com-
pared with normal murine keratinocytes (11.2%  1.8%) at
day 9 (Fig 2J–L). Our observations are consistent with the
results of Nagavarapu et al (2002) who found that transfect-
ion of epidermal keratinocytes with an anti-sense MT1-
MMP oligonucleotide correlated to reduced migration and
increased apoptosis.
Several alternative mechanisms alone or together could
explain the impaired early migration and increased apop-
tosis in MT1-MMP/ keratinocytes during the late phase of
epidermalization. MT1-MMP is known to cleave laminin-5, a
component of the basement membrane substratum in our
ex vivo model, directly and indirectly through pro-MMP-2
activation. In migrating mammary epithelial cells, MT1-MMP
was redistributed to lamellipodia and basal surface, sup-
posedly to enable the cells to remodel ECM molecules such
as laminin-5 (Gilles et al, 2001). Thus, abolished generation
of pro-migratory ECM molecules by the MT1-MMP-defi-
cient keratinocytes may have attenuated migration. MT1-
MMP not only hydrolyzes ECM components but also inter-
acts with and activates integrin receptors. By processing
integrin subunits, MT1-MMP facilitates integrin-dependent
cell adhesion and activates the focal adhesion kinase (FAK)
signaling pathway (Baciu et al, 2003). Migration of human
keratinocytes was also attributed to induction and phos-
phorylation of FAK (Yurko et al, 2001). Furthermore, FAK
activation was associated with resistance to apoptosis
caused by disrupted interaction between epithelial cells and
ECM (Frisch et al, 1996). Consequently, reduced FAK ac-
tivation in MT1-MMP/ keratinocytes could explain the
reduced migration and increased apoptosis.
In conclusion, despite uncompromised closure of small
wounds in neonatal mice with disrupted MT1-MMP gene,
their skin showed impaired epidermalization on basement
membrane substratum ex vivo. Whether our findings can be
extrapolated to wound healing in vivo underlies further re-
search. Nonetheless, we postulate that MT1-MMP is asso-
ciated with the survival of epidermal keratinocytes.
Figure 1
In vivo murine wound closure and zymography. Wound closure in (A)
normal 3-d-old mice injected subcutaneously and daily, starting 2 d prior
to wounding, with the global hydroxamate matrix metalloproteinase
(MMP) inhibitor GM 6001 (100 mg per g body weight) or vehicle alone
(Lund et al, 1999) and in (B) littermate and membrane-type-1 matrix
metalloproteinase-deficient (MT1-MMP/) mice. Wound areas were de-
termined by digital planimetry from tracings of outer wound margins and
data analyzed by the t test. Error bars: SEM. (C) A representative gelatin
zymogram of electrophoresed tissue extracts (15 mg total protein per
lane), prepared in the presence of a proteinase inhibitor cocktail (Ca-
lbiochem, Darmstadt, Germany) for 18 h at 41C (Mirastschijski et al,
2002), of normal skin (day 0) and wounds. (D) Zymograms of tissue ex-
tracts in the absence (DTT) or presence (þDTT) of 50 mM dithiothreitol
(DTT) in the sample buffer (Peeters-Joris et al, 1998), or after pre-treat-
ment without or with 1 mM 4-aminophenylmercuric acetate (APMA) at
371C for 2 h. (C, D) 1, normal; 2, MT1-MMP/; (D) 3, no APMA; 4, APMA.
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Figure2
Ex vivo murine epidermalization, proliferation, and
apoptosis. (A) Laminin-1 immunostaining of non-cul-
tured deepidermized dermal (DED) substrate. (B) Ster-
eo-microscopical view and (C) skin culture composite
with arrowed regenerating epithelium from a skin ex-
plant over DED substrate. (D, E) Green fluorescent neo-
epithelium with arrowed front. (F) Quantification of
fluorescent neoepithelium from membrane-type-1 ma-
trix metalloproteinase-deficient (MT1-MMP/) skin ex-
plants from seven animals from five different litters and
normal skin explants from 13 animals of the same five
litters cultured in Dulbecco’s modified Eagle’s medium/
Ham’s F-12 (3:1) containing 5 mg insulin, 0.5 mg hydro-
cortisone, and 10 ng epidermal growth factor per mL,
1010 M cholera enterotoxin, 1.8  104 M adenine,
non-essential amino acids, 10% fetal calf serum, and
100 mg streptomycin, and 100 U penicillin per mL. (G, H)
DNA-synthesizing keratinocytes in neoepithelium (ar-
rows) were immunodetected after a 4-h pulse with 50
mM 5-bromo-20-deoxyuridine (BrdU) by their red nuclei
(Mirastschijski et al, 2002). (I) BrdU labeling index, i.e.,
number of BrdU-positive cells per total number of
cells  100% in neoepithelium, determinations for the
two mouse groups. (J, K) Apoptotic cells (brown nuclei)
were immunodetected after terminal deoxytransferase-
mediated digoxigenin-dUTP nick end labeling (Apop-
Tag, Intergen Company, Purchase, New York) treatment
of 5-mm paraffin tissue sections. All dermal cells (arrow-
heads) in DED and explant were apoptotic. (L) Apoptotic
index, i.e., number of apoptotic cells per total number of
cells  100%, determined in neoepithelium from MT1-
MMP/ and MT1-MMP expressing skin explants. (D, G,
J) Normal. (B, C, E, H, K) MT1-MMP/. (C, D, E, G, H, J,
K) day 9. (F, I, L) Data analyzed by the t test. (A, C, G, H,
J, K) Same magnification. Scale bars: (B, E): 1 mm; (C,
H, K) 100 mm; ex, explant; ep, neoepithelium; DED,
deepidermized dermis. Error bars: SEM.
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